(IN BRIEF) Researchers at The Institute of Cancer Research, London, have published a study in Trials showing that some UK cancer clinical trials may still include eligibility criteria that unintentionally restrict access for underserved patient groups. The study, conducted by … Read the full press release
Posted in Business, Education, Government, Healthcare, Law, Pharma & Biotech, Science, Society, Technology, United Kingdom
Tagged bladder cancer, cancer care, cancer clinical trials, cancer research, cancer treatment access, clinical research barriers, clinical trial eligibility criteria, clinical trial inclusion, Clinical Trials and Statistics Unit, Dr Georgiana Synesi, EDI, equality diversity and inclusion, geographical barriers, head and neck cancer, Health Research Authority, HIV exclusion criteria, ICR, ICR Study Identifies Persistent Barriers to Inclusive Participation in UK Cancer Clinical Trials, ICR-CTSU, INCLUDE Project, inclusive trial design, Institute of Cancer Research Review Highlights How Eligibility Criteria May Limit Access to Cancer Trials, Language Support, medical advances, Medicines and Healthcare products Regulatory Agency, MHRA, multi-centre randomised controlled trials, National Institute for Health and Care Research, New ICR Study Calls for More Inclusive Design of Bladder and Head and Neck Cancer Clinical Trials, NIHR-INCLUDE, oncology research, patient access, patient safety, people living with HIV, personalised cancer research, phase II trials, Phase III Trials, Professor Emma Hall, Rebecca Lewis, The Institute of Cancer Research, trial participation, Trials journal, UK cancer trials, underserved populations
EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction Icon Group is Australia’s largest vertically integrated cancer … Read the full press release
Posted in Business, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged acquisition, Australia, Blikk, cancer care, cancer clinical trials, cancer drug infusions, cancer patients, cancer treatment, compounding, decentralisation, Deloitte, diagnostic imaging provider, digitalization, EQT, EQT Infrastructure, EQT Infrastructure V, Goldman Sachs Asset Management, healthcare sector, Herbert Smith Freehills, I-MED, Icon Group, integrated cancer-care operator, Integrated Clinical Oncology Network, investment, Jim Kelly, Ken Wong, Mark Middleton, medical oncology, Meine Radiologie Holding, Morgan Stanley, nuclear medicine, oncology, Pagoda Investment Advisors, pharmacy, PwC, QIC Private Capital Pty Ltd, Radiation Oncology, radiology, radiotherapy, Stephanie Hui
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?